5-alpha Reductase Inhibitor [EPC]

5-alpha Reductase Inhibitor [EPC] was reported 102491 times

These side effects are most commonly reported by patients taking drugs of the 5-alpha Reductase Inhibitor [EPC] class:

# Drug class Count
0 ADVERSE DRUG REACTION 11423
1 DRUG INEFFECTIVE 9309
2 FATIGUE 5098
3 ERECTILE DYSFUNCTION 4537
4 DEPRESSION 4002
5 OFF LABEL USE 3950
6 DIZZINESS 3669
7 ANXIETY 3592
8 DYSPNOEA 3393
9 DIARRHOEA 3255
10 HEADACHE 3074
11 ASTHENIA 2911
12 DEATH 2775
13 INSOMNIA 2687
14 APPLICATION SITE PRURITUS 2625
15 SEXUAL DYSFUNCTION 2515
16 NAUSEA 2451
17 FALL 2433
18 RASH 2014
19 ARTHRALGIA 1971
20 CONDITION AGGRAVATED 1953
21 PAIN 1950
22 PRURITUS 1917
23 LIBIDO DECREASED 1809
24 LOSS OF LIBIDO 1786
25 SUICIDAL IDEATION 1747
26 MALAISE 1698
27 ADVERSE EVENT 1695
28 ALOPECIA 1670
29 PNEUMONIA 1667
30 COGNITIVE DISORDER 1601
31 WEIGHT DECREASED 1572
32 COUGH 1548
33 CONSTIPATION 1546
34 DECREASED APPETITE 1487
35 PAIN IN EXTREMITY 1408
36 HYPERTENSION 1397
37 HYPOTENSION 1384
38 VOMITING 1361
39 ACUTE KIDNEY INJURY 1294
40 APPLICATION SITE IRRITATION 1273
41 BACK PAIN 1262
42 CONFUSIONAL STATE 1240
43 FEELING ABNORMAL 1224
44 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1221
45 ATRIAL FIBRILLATION 1190
46 MYALGIA 1187
47 CHEST PAIN 1183
48 PYREXIA 1155
49 BLOOD PRESSURE INCREASED 1151
50 SOMNOLENCE 1145
51 APPLICATION SITE PAIN 1140
52 ANAEMIA 1105
53 ABDOMINAL PAIN 1104
54 URINARY TRACT INFECTION 1075
55 WEIGHT INCREASED 1049
56 DRUG INTERACTION 1025
57 GAIT DISTURBANCE 1005
58 HYPERSENSITIVITY 979
59 INCORRECT DOSE ADMINISTERED 971
60 RENAL FAILURE 963
61 CHRONIC KIDNEY DISEASE 952
62 SYNCOPE 942
63 PERIPHERAL SWELLING 926
64 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 921
65 VISION BLURRED 911
66 PRODUCT USE IN UNAPPROVED INDICATION 901
67 PRODUCT DOSE OMISSION ISSUE 892
68 ABDOMINAL PAIN UPPER 882
69 PALPITATIONS 853
70 OEDEMA PERIPHERAL 851
71 MEMORY IMPAIRMENT 842
72 MUSCLE SPASMS 842
73 MUSCULAR WEAKNESS 839
74 PRODUCT USE ISSUE 833
75 ASTHMA 827
76 HALLUCINATION 786
77 SEPSIS 777
78 TREMOR 761
79 TESTICULAR PAIN 755
80 APPLICATION SITE DRYNESS 754
81 GASTROOESOPHAGEAL REFLUX DISEASE 737
82 DRY SKIN 736
83 PRODUCTIVE COUGH 735
84 EJACULATION DISORDER 734
85 HAEMATURIA 731
86 GYNAECOMASTIA 730
87 WHEEZING 729
88 TINNITUS 727
89 HYPOAESTHESIA 726
90 HAEMOGLOBIN DECREASED 719
91 COVID-19 717
92 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 702
93 DEHYDRATION 699
94 CARDIAC FAILURE CONGESTIVE 692
95 ANHEDONIA 691
96 CEREBROVASCULAR ACCIDENT 685
97 DYSURIA 674
98 ERYTHEMA 674
99 PARAESTHESIA 673
100 URINARY RETENTION 669
101 DISTURBANCE IN ATTENTION 668
102 BALANCE DISORDER 665
103 CHILLS 663
104 PULMONARY EMBOLISM 663
105 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 660
106 DEPRESSED MOOD 658
107 AMNESIA 657
108 SLEEP DISORDER 655
109 THROMBOSIS 650
110 APPLICATION SITE ERYTHEMA 646
111 ABDOMINAL DISCOMFORT 645
112 MYOCARDIAL INFARCTION 643
113 MUSCLE ATROPHY 619
114 BLOOD GLUCOSE INCREASED 609
115 POLLAKIURIA 608
116 TACHYCARDIA 592
117 GASTROINTESTINAL HAEMORRHAGE 587
118 DYSPEPSIA 584
119 LOSS OF CONSCIOUSNESS 582
120 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 581
121 NASOPHARYNGITIS 581
122 NEUROPATHY PERIPHERAL 575
123 HEART RATE INCREASED 568
124 PLATELET COUNT DECREASED 568
125 DYSPHAGIA 561
126 SKIN EXFOLIATION 556
127 APPLICATION SITE EXFOLIATION 552
128 EJACULATION FAILURE 551
129 HOSPITALISATION 547
130 HYPERHIDROSIS 544
131 PANIC ATTACK 539
132 URTICARIA 538
133 CHEST DISCOMFORT 528
134 MEDICATION ERROR 527
135 HOT FLUSH 520
136 BENIGN PROSTATIC HYPERPLASIA 517
137 SEMEN VOLUME DECREASED 516
138 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 513
139 DANDRUFF 510
140 EYE PAIN 510
141 ABDOMINAL DISTENSION 509
142 CONTUSION 507
143 THROMBOCYTOPENIA 494
144 GENERAL PHYSICAL HEALTH DETERIORATION 492
145 VISUAL IMPAIRMENT 488
146 BRAIN FOG 487
147 HYPOXIA 486
148 OVERDOSE 475
149 WHITE BLOOD CELL COUNT DECREASED 470
150 RENAL IMPAIRMENT 468
151 INFECTION 458
152 PROSTATE CANCER 458
153 BLOOD PRESSURE DECREASED 457
154 EPISTAXIS 452
155 HAIR TEXTURE ABNORMAL 452
156 EXPIRED PRODUCT ADMINISTERED 451
157 APPLICATION SITE RASH 449
158 HAEMORRHAGE 449
159 COMPLETED SUICIDE 445
160 BLOOD CREATININE INCREASED 440
161 LETHARGY 439
162 CARDIAC DISORDER 438
163 SWELLING FACE 433
164 BLOOD TESTOSTERONE DECREASED 432
165 DRY MOUTH 431
166 FULL BLOOD COUNT ABNORMAL 426
167 EMOTIONAL DISTRESS 424
168 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 421
169 PENILE SIZE REDUCED 412
170 BRADYCARDIA 411
171 DYSPNOEA EXERTIONAL 410
172 SLEEP APNOEA SYNDROME 409
173 INFLUENZA 403
174 DRUG HYPERSENSITIVITY 396
175 JOINT SWELLING 396
176 UNDERDOSE 394
177 CARDIAC FAILURE 392
178 PLEURAL EFFUSION 391
179 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 390
180 NEUTROPENIA 389
181 PRESYNCOPE 384
182 RHINORRHOEA 383
183 NO ADVERSE EVENT 382
184 VERTIGO 382
185 AGITATION 379
186 DISEASE PROGRESSION 378
187 FLUSHING 378
188 OROPHARYNGEAL PAIN 378
189 STRESS 376
190 ARTERIOSCLEROSIS 371
191 DIPLOPIA 366
192 DRUG DOSE OMISSION 363
193 CARDIO-RESPIRATORY ARREST 362
194 END STAGE RENAL DISEASE 361
195 OBSTRUCTIVE AIRWAYS DISORDER 361
196 HAEMATEMESIS 360
197 PENIS DISORDER 358
198 ARRHYTHMIA 356
199 HAEMOPTYSIS 356
200 ORTHOSTATIC HYPOTENSION 356
201 BLINDNESS 354
202 FLATULENCE 353
203 NODULE 350
204 HEAD DISCOMFORT 347
205 SINUSITIS 345
206 DYSGEUSIA 343
207 ALTERED STATE OF CONSCIOUSNESS 342
208 HAIR COLOUR CHANGES 342
209 INTENTIONAL PRODUCT USE ISSUE 340
210 LUNG DISORDER 338
211 ACNE 336
212 INJECTION SITE PAIN 336
213 MOBILITY DECREASED 336
214 DRUG ADMINISTRATION ERROR 333
215 HYPOTHYROIDISM 333
216 BRONCHITIS 332
217 COMA 331
218 CONJUNCTIVITIS ALLERGIC 328
219 ARTHRITIS 327
220 HYPOACUSIS 327
221 NECK PAIN 327
222 CATARACT 325
223 NOCTURIA 324
224 RECTAL HAEMORRHAGE 323
225 MENTAL DISORDER 322
226 OXYGEN SATURATION DECREASED 322
227 ACCIDENTAL EXPOSURE TO PRODUCT 319
228 IRRITABILITY 318
229 PRODUCT QUALITY ISSUE 318
230 SEIZURE 318
231 NORMOCHROMIC NORMOCYTIC ANAEMIA 317
232 SWELLING 317
233 ASCITES 316
234 DYSPHONIA 314
235 HYPOGONADISM 314
236 NEPHROLITHIASIS 314
237 GASTROINTESTINAL DISORDER 313
238 FLUID RETENTION 312
239 HAEMORRHAGIC STROKE 312
240 TOXICITY TO VARIOUS AGENTS 312
241 OSTEOPOROSIS 310
242 DRY EYE 309
243 RESPIRATORY FAILURE 307
244 MITE ALLERGY 306
245 DUST ALLERGY 305
246 APATHY 304
247 MYCOTIC ALLERGY 304
248 ARTERIOSCLEROSIS CORONARY ARTERY 303
249 SPIROMETRY ABNORMAL 303
250 INTENTIONAL PRODUCT MISUSE 301
251 DEEP VEIN THROMBOSIS 299
252 MUSCULOSKELETAL STIFFNESS 299
253 PSORIASIS 299
254 HYPERTRICHOSIS 293
255 PROSTATOMEGALY 292
256 OEDEMA 290
257 HYPERKALAEMIA 288
258 OCULAR DISCOMFORT 283
259 ECZEMA 282
260 EYE IRRITATION 282
261 GENITAL HYPOAESTHESIA 281
262 MIGRAINE 280
263 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 279
264 PROSTATIC SPECIFIC ANTIGEN INCREASED 279
265 AGGRESSION 276
266 CELLULITIS 273
267 GOUT 272
268 CARDIAC ARREST 269
269 MUSCLE TWITCHING 268
270 PARKINSON^S DISEASE 268
271 PHOTOPHOBIA 268
272 PULMONARY OEDEMA 268
273 PANCYTOPENIA 267
274 THERAPY INTERRUPTED 264
275 MUSCULOSKELETAL PAIN 263
276 BLISTER 262
277 SKIN IRRITATION 261
278 SPEECH DISORDER 261
279 CORONARY ARTERY DISEASE 260
280 GENERALISED OEDEMA 260
281 HYPONATRAEMIA 260
282 MOOD SWINGS 260
283 URINARY TRACT DISORDER 260
284 ACUTE MYOCARDIAL INFARCTION 257
285 OSTEOARTHRITIS 257
286 RASH PRURITIC 256
287 URINARY INCONTINENCE 256
288 BURNING SENSATION 254
289 DRUG INTOLERANCE 252
290 ILLNESS 252
291 MALIGNANT NEOPLASM PROGRESSION 252
292 BONE PAIN 251
293 ALANINE AMINOTRANSFERASE INCREASED 250
294 ORGANIC ERECTILE DYSFUNCTION 249
295 ANGINA PECTORIS 248
296 INTERNATIONAL NORMALISED RATIO INCREASED 248
297 SKIN DISCOLOURATION 248
298 HEART RATE DECREASED 247
299 NASAL CONGESTION 246
300 THERAPY CESSATION 246
301 PEYRONIE^S DISEASE 245
302 TESTICULAR ATROPHY 245
303 TRANSIENT ISCHAEMIC ATTACK 245
304 HALLUCINATION, VISUAL 243
305 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 242
306 HYPERLIPIDAEMIA 242
307 FEBRILE NEUTROPENIA 238
308 MENTAL IMPAIRMENT 238
309 PERICARDIAL EFFUSION 238
310 SURGERY 237
311 UNEVALUABLE EVENT 237
312 ASPARTATE AMINOTRANSFERASE INCREASED 236
313 DISORIENTATION 234
314 PULMONARY FIBROSIS 234
315 BLOOD URINE PRESENT 233
316 PRODUCT SUBSTITUTION ISSUE 232
317 RED BLOOD CELL COUNT DECREASED 232
318 RENAL DISORDER 232
319 ARTHROPATHY 231
320 AMAUROSIS FUGAX 230
321 DEMENTIA 230
322 HYPOKALAEMIA 230
323 RENAL FAILURE ACUTE 227
324 DIABETES MELLITUS 226
325 HAEMATOCHEZIA 226
326 THERAPEUTIC RESPONSE UNEXPECTED 226
327 DYSARTHRIA 224
328 FEELING HOT 224
329 HEAD INJURY 222
330 WRONG TECHNIQUE IN DRUG USAGE PROCESS 219
331 MOOD ALTERED 218
332 APPLICATION SITE SCAB 217
333 BLOOD CHOLESTEROL INCREASED 217
334 BLOOD PRESSURE FLUCTUATION 216
335 HORMONE LEVEL ABNORMAL 215
336 THERAPEUTIC RESPONSE DECREASED 215
337 WHITE BLOOD CELL COUNT INCREASED 215
338 HAEMORRHOIDS 214
339 PROSTATITIS 214
340 RHABDOMYOLYSIS 214
341 ANGER 212
342 SKIN DISORDER 212
343 DYSSTASIA 211
344 EMOTIONAL DISORDER 209
345 RESTLESSNESS 209
346 UPPER RESPIRATORY TRACT INFECTION 208
347 DYSKINESIA 206
348 HYPOGLYCAEMIA 206
349 DELIRIUM 204
350 EYE SWELLING 204
351 NIGHTMARE 203
352 PLASMA CELL MYELOMA 203
353 RENAL INJURY 203
354 HAIR GROWTH ABNORMAL 200
355 STOMATITIS 200
356 UPPER GASTROINTESTINAL HAEMORRHAGE 200
357 PRODUCT DOSE OMISSION 199
358 CEREBRAL HAEMORRHAGE 198
359 INFLUENZA LIKE ILLNESS 198
360 ANORGASMIA 197
361 LIP SWELLING 197
362 DISEASE RECURRENCE 196
363 HERPES ZOSTER 195
364 NEPHROGENIC ANAEMIA 194
365 MICTURITION URGENCY 193
366 HEART RATE IRREGULAR 192
367 LOWER RESPIRATORY TRACT INFECTION 192
368 LYMPHADENOPATHY 192
369 CHOLELITHIASIS 191
370 BRAIN INJURY 190
371 NEUROLOGICAL SYMPTOM 189
372 THERAPEUTIC PRODUCT EFFECT DECREASED 189
373 NIGHT SWEATS 188
374 PULMONARY ALVEOLAR HAEMORRHAGE 188
375 RESPIRATORY SYMPTOM 184
376 FAECES DISCOLOURED 183
377 CONTRAINDICATED PRODUCT ADMINISTERED 182
378 LIVER FUNCTION TEST ABNORMAL 182
379 AGEUSIA 181
380 HYPERSOMNIA 181
381 INTERVERTEBRAL DISC DEGENERATION 181
382 DRUG ADMINISTERED AT INAPPROPRIATE SITE 180
383 DEVICE ISSUE 179
384 DISCOMFORT 179
385 RASH ERYTHEMATOUS 178
386 DRUG EFFECT DECREASED 175
387 NEURITIS 175
388 LIMB INJURY 174
389 BLOOD CREATINE PHOSPHOKINASE INCREASED 173
390 BLOOD PRESSURE SYSTOLIC INCREASED 173
391 CYSTITIS 173
392 DEPRESSED LEVEL OF CONSCIOUSNESS 172
393 VASCULITIS 172
394 INJURY 171
395 NERVOUSNESS 171
396 APHASIA 170
397 THINKING ABNORMAL 170
398 HIP FRACTURE 169
399 PROSTATIC DISORDER 169
400 SKIN BURNING SENSATION 168
401 TREATMENT NONCOMPLIANCE 168
402 BRONCHIECTASIS 167
403 POOR QUALITY SLEEP 167
404 PULMONARY VASCULITIS 167
405 ROAD TRAFFIC ACCIDENT 167
406 SUBDURAL HAEMATOMA 167
407 THROAT IRRITATION 167
408 MAJOR DEPRESSION 166
409 HEPATIC ENZYME INCREASED 165
410 SUICIDE ATTEMPT 165
411 THERAPY NON-RESPONDER 165
412 NEOPLASM MALIGNANT 164
413 PRODUCT ADMINISTRATION ERROR 164
414 RENAL CYST 164
415 JOINT INJURY 163
416 OCULAR HYPERAEMIA 163
417 RIB FRACTURE 163
418 APPLICATION SITE PAPULES 160
419 SKIN LESION 160
420 TESTICULAR DISORDER 160
421 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 159
422 RESTLESS LEGS SYNDROME 159
423 MELAENA 155
424 MENTAL STATUS CHANGES 155
425 PRODUCT PRESCRIBING ISSUE 154
426 BLOOD POTASSIUM INCREASED 153
427 PNEUMONIA ASPIRATION 153
428 BLOOD POTASSIUM DECREASED 152
429 BREAST PAIN 152
430 PSYCHOTIC DISORDER 151
431 RASH MACULAR 150
432 BASAL CELL CARCINOMA 149
433 FULL BLOOD COUNT DECREASED 149
434 CHROMATURIA 147
435 INFLAMMATION 147
436 INTERVERTEBRAL DISC PROTRUSION 147
437 SKIN CANCER 147
438 BLOOD GLUCOSE DECREASED 146
439 JOINT STIFFNESS 146
440 MIDDLE INSOMNIA 146
441 LOCALISED INFECTION 145
442 NERVOUS SYSTEM DISORDER 145
443 TYPE 2 DIABETES MELLITUS 144
444 DEPRESSION SUICIDAL 143
445 FEELING COLD 143
446 OBESITY 143
447 BLADDER CANCER 142
448 GAIT INABILITY 142
449 GROIN PAIN 142
450 HAEMATOCRIT DECREASED 142
451 ABNORMAL BEHAVIOUR 141
452 NEURALGIA 141
453 HYPERCHOLESTEROLAEMIA 140
454 LIBIDO DISORDER 140
455 ACUTE RESPIRATORY FAILURE 139
456 INTESTINAL OBSTRUCTION 138
457 LACRIMATION INCREASED 138
458 ANGIOEDEMA 137
459 PANCREATITIS 137
460 RHEUMATOID ARTHRITIS 137
461 SWOLLEN TONGUE 137
462 APPLICATION SITE ULCER 136
463 BLOOD UREA INCREASED 136
464 FORCED EXPIRATORY VOLUME DECREASED 136
465 ILL-DEFINED DISORDER 136
466 INFUSION RELATED REACTION 136
467 ABDOMINAL PAIN LOWER 135
468 BLOOD COUNT ABNORMAL 135
469 SKIN ULCER 135
470 TASTE DISORDER 135
471 BREAST TENDERNESS 134
472 HOSPICE CARE 134
473 ABNORMAL DREAMS 133
474 BREAST ENLARGEMENT 133
475 DERMATITIS ATOPIC 133
476 DRUG ABUSE 133
477 ELECTROCARDIOGRAM QT PROLONGED 133
478 HAEMATOMA 133
479 NIPPLE PAIN 133
480 DELUSION 132
481 DIVERTICULITIS 132
482 LABORATORY TEST ABNORMAL 132
483 PALLOR 132
484 HEPATIC FUNCTION ABNORMAL 131
485 ORGASM ABNORMAL 131
486 DIZZINESS POSTURAL 130
487 PENILE PAIN 130
488 UNRESPONSIVE TO STIMULI 130
489 DEAFNESS 129
490 DECREASED INTEREST 129
491 MALE ORGASMIC DISORDER 129
492 STAPHYLOCOCCAL INFECTION 129
493 HYPOPHAGIA 128
494 QUALITY OF LIFE DECREASED 128
495 BLOOD PRESSURE ABNORMAL 127
496 SKIN ATROPHY 127
497 HERNIA 126
498 INJECTION SITE ERYTHEMA 126
499 LEUKOPENIA 126
500 VISUAL ACUITY REDUCED 126
501 DRUG WITHDRAWAL SYNDROME 125
502 LIVER DISORDER 124
503 APPLICATION SITE VESICLES 123
504 BLOOD SODIUM DECREASED 123
505 INTERSTITIAL LUNG DISEASE 123
506 LIMB DISCOMFORT 123
507 TUBULOINTERSTITIAL NEPHRITIS 123
508 ACCIDENTAL OVERDOSE 121
509 COLITIS 121
510 GASTRITIS 121
511 THROAT TIGHTNESS 121
512 URINE FLOW DECREASED 121
513 VITAMIN D DEFICIENCY 121
514 BLOOD ALKALINE PHOSPHATASE INCREASED 120
515 IMPAIRED QUALITY OF LIFE 120
516 JAUNDICE 120
517 PULMONARY FUNCTION TEST ABNORMAL 120
518 DIASTOLIC DYSFUNCTION 119
519 FREQUENT BOWEL MOVEMENTS 119
520 INTENTIONAL DOSE OMISSION 119
521 TOTAL LUNG CAPACITY ABNORMAL 119
522 AFFECTIVE DISORDER 118
523 EYE DISORDER 118
524 VENTRICULAR TACHYCARDIA 118
525 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 117
526 CONVULSION 117
527 HYPERPARATHYROIDISM SECONDARY 117
528 IRRITABLE BOWEL SYNDROME 117
529 PRODUCT STORAGE ERROR 117
530 WOUND 117
531 CROHN^S DISEASE 116
532 PAIN IN JAW 116
533 HEPATIC STEATOSIS 114
534 PERIPHERAL COLDNESS 114
535 SEPTIC SHOCK 114
536 SINUS DISORDER 114
537 WITHDRAWAL SYNDROME 114
538 FEAR 113
539 GLYCOSYLATED HAEMOGLOBIN INCREASED 113
540 MOVEMENT DISORDER 113
541 NEUTROPHIL COUNT DECREASED 113
542 ROTATOR CUFF SYNDROME 113
543 OBSTRUCTION 112
544 PNEUMONITIS 112
545 VITREOUS FLOATERS 112
546 HYPERGLYCAEMIA 111
547 IMPAIRED HEALING 111
548 CLOSTRIDIUM DIFFICILE INFECTION 110
549 INGUINAL HERNIA 110
550 RASH PAPULAR 110
551 AORTIC VALVE STENOSIS 109
552 BLOOD BILIRUBIN INCREASED 109
553 INCORRECT DRUG ADMINISTRATION DURATION 109
554 INJECTION SITE HAEMORRHAGE 109
555 SENSORY LOSS 109
556 ATRIAL FLUTTER 108
557 ORAL PAIN 108
558 PULMONARY HYPERTENSION 108
559 SPLENOMEGALY 108
560 BODY HEIGHT DECREASED 107
561 BREAST MASS 107
562 ENCEPHALOPATHY 107
563 MALE SEXUAL DYSFUNCTION 107
564 SEMEN ANALYSIS ABNORMAL 107
565 SOCIAL AVOIDANT BEHAVIOUR 107
566 APPLICATION SITE ACNE 106
567 C-REACTIVE PROTEIN INCREASED 106
568 PENIS INJURY 106
569 RESPIRATORY TRACT INFECTION 106
570 COLITIS ULCERATIVE 105
571 DRUG EFFECT INCOMPLETE 105
572 PSYCHIATRIC SYMPTOM 105
573 SPINAL OSTEOARTHRITIS 105
574 TREATMENT FAILURE 105
575 APPLICATION SITE BURN 104
576 BRADYPHRENIA 104
577 ECONOMIC PROBLEM 104
578 PRODUCT PRESCRIBING ERROR 104
579 VIRAL INFECTION 104
580 CORONARY ARTERY OCCLUSION 103
581 DERMATITIS 103
582 GAMMA-GLUTAMYLTRANSFERASE INCREASED 103
583 PRODUCT DOSE OMISSION IN ERROR 103
584 VENTRICULAR EXTRASYSTOLES 103
585 CHEST X-RAY ABNORMAL 102
586 COLD SWEAT 102
587 SEASONAL ALLERGY 102
588 THIRST 102
589 TOOTH DISORDER 102
590 TENDONITIS 101
591 CEREBRAL INFARCTION 100
592 CLOSTRIDIUM DIFFICILE COLITIS 100
593 DRUG EXPOSURE DURING PREGNANCY 100
594 SPERM CONCENTRATION DECREASED 100
595 DRUG EFFECT LESS THAN EXPECTED 99
596 GLAUCOMA 99
597 LACTIC ACIDOSIS 99
598 ERUCTATION 98
599 PRODUCT FORMULATION ISSUE 98
600 BRONCHIAL SECRETION RETENTION 97
601 LACERATION 97
602 MUSCULOSKELETAL DISCOMFORT 97
603 ORGASMIC SENSATION DECREASED 97
604 PARANOIA 97
605 VARICOCELE 97
606 BACK INJURY 96
607 BLOOD IRON DECREASED 96
608 FEEDING DISORDER 96
609 HYPOCALCAEMIA 96
610 LUNG NEOPLASM MALIGNANT 96
611 OSTEOMYELITIS 96
612 OSTEOPENIA 96
613 PRESCRIBED UNDERDOSE 96
614 INJECTION SITE SWELLING 95
615 LARGE INTESTINE POLYP 95
616 PAINFUL EJACULATION 95
617 RESPIRATORY DISORDER 95
618 BODY TEMPERATURE DECREASED 94
619 HAEMORRHAGE INTRACRANIAL 94
620 METABOLIC ACIDOSIS 94
621 POST PROCEDURAL HAEMORRHAGE 94
622 PSORIATIC ARTHROPATHY 94
623 APPLICATION SITE REACTION 93
624 EYE PRURITUS 93
625 PREMATURE EJACULATION 93
626 SEBORRHOEA 93
627 SENSORY DISTURBANCE 93
628 EAR PAIN 92
629 GINGIVAL RECESSION 92
630 RIGHT VENTRICULAR HYPERTROPHY 92
631 ABNORMAL LOSS OF WEIGHT 91
632 BACK DISORDER 91
633 DRUG-INDUCED LIVER INJURY 91
634 HYPOMAGNESAEMIA 91
635 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 91
636 LOWER GASTROINTESTINAL HAEMORRHAGE 91
637 MELANOCYTIC NAEVUS 91
638 PHOTOSENSITIVITY REACTION 91
639 RIGHT ATRIAL HYPERTROPHY 91
640 INCONTINENCE 90
641 LEUKOCYTOSIS 90
642 MITRAL VALVE INCOMPETENCE 90
643 PRURITUS GENERALISED 90
644 RENAL FAILURE CHRONIC 90
645 FLUID OVERLOAD 89
646 POST PROCEDURAL COMPLICATION 89
647 BRONCHIAL WALL THICKENING 88
648 DERMATITIS CONTACT 88
649 DIVERTICULUM 88
650 EXPOSURE VIA SKIN CONTACT 88
651 GLOMERULAR FILTRATION RATE DECREASED 88
652 PROTEINURIA 88
653 RALES 88
654 GASTRIC DISORDER 87
655 GASTRIC ULCER 87
656 HYPOGONADISM MALE 87
657 MUSCLE TIGHTNESS 87
658 MUSCULOSKELETAL CHEST PAIN 87
659 PRODUCT DISPENSING ERROR 87
660 PROSTATIC PAIN 87
661 SCAB 87
662 THERAPEUTIC RESPONSE SHORTENED 87
663 ATELECTASIS 86
664 ESSENTIAL HYPERTENSION 86
665 INJECTION SITE BRUISING 86
666 LIGAMENT SPRAIN 86
667 RASH GENERALISED 86
668 BREAST CANCER 85
669 CARDIOMEGALY 85
670 EJECTION FRACTION DECREASED 85
671 FUNGAL INFECTION 85
672 INTERNAL HAEMORRHAGE 85
673 LUNG INFECTION 85
674 MYOPATHY 85
675 PULMONARY MASS 85
676 ABASIA 84
677 ANAPHYLACTIC REACTION 84
678 BONE DISORDER 84
679 BOWEL MOVEMENT IRREGULARITY 84
680 INCORRECT PRODUCT ADMINISTRATION DURATION 84
681 MALIGNANT MELANOMA 84
682 MUSCLE STRAIN 84
683 RESPIRATORY DISTRESS 84
684 SCIATICA 84
685 ENDOCRINE DISORDER 83
686 KNEE ARTHROPLASTY 83
687 SOPOR 83
688 BLADDER DISORDER 82
689 CHOKING 82
690 GENITAL PAIN 82
691 MUSCLE DISORDER 82
692 MYELODYSPLASTIC SYNDROME 82
693 PEMPHIGOID 82
694 CIRCULATORY COLLAPSE 81
695 CONTRAINDICATED PRODUCT PRESCRIBED 81
696 CYST 81
697 EATING DISORDER 81
698 FEELING JITTERY 81
699 GENITAL ATROPHY 81
700 HYPERTHYROIDISM 81
701 IMPAIRED WORK ABILITY 81
702 MYOCLONUS 81
703 PERSONALITY CHANGE 81
704 BLOOD TRIGLYCERIDES INCREASED 80
705 EPIDIDYMITIS 80
706 INFERTILITY MALE 80
707 INTENTIONAL OVERDOSE 80
708 TENDON RUPTURE 80
709 UROSEPSIS 80
710 ASPIRATION 79
711 CAPILLARITIS 79
712 MASS 79
713 PANCREATITIS ACUTE 79
714 RETROGRADE EJACULATION 79
715 SKIN LACERATION 79
716 SNEEZING 79
717 ANDROGEN DEFICIENCY 78
718 BODY TEMPERATURE INCREASED 78
719 FEMUR FRACTURE 78
720 LEFT VENTRICULAR HYPERTROPHY 78
721 RETCHING 78
722 RHINITIS ALLERGIC 78
723 THYROID DISORDER 78
724 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 77
725 EAR INFECTION 77
726 HIATUS HERNIA 77
727 SKIN HAEMORRHAGE 77
728 ANGINA UNSTABLE 76
729 COAGULOPATHY 76
730 INJECTION SITE PRURITUS 76
731 IRON DEFICIENCY ANAEMIA 76
732 KNEE OPERATION 76
733 CARDIAC MURMUR 75
734 OSTEONECROSIS 75
735 SKIN REACTION 75
736 TESTICULAR FAILURE 75
737 AORTIC ANEURYSM 74
738 BONE DENSITY DECREASED 74
739 NEOPLASM PROGRESSION 74
740 PRODUCT AVAILABILITY ISSUE 74
741 TOOTHACHE 74
742 BACTERIAL INFECTION 73
743 BLOOD MAGNESIUM DECREASED 73
744 GINGIVAL BLEEDING 73
745 HAEMATOSPERMIA 73
746 OBSESSIVE-COMPULSIVE DISORDER 73
747 PAPULE 73
748 PARKINSONISM 73
749 PENILE CURVATURE 73
750 RESPIRATORY TRACT CONGESTION 73
751 SQUAMOUS CELL CARCINOMA 73
752 ATRIOVENTRICULAR BLOCK 72
753 CARPAL TUNNEL SYNDROME 72
754 DISTURBANCE IN SEXUAL AROUSAL 72
755 DRUG DEPENDENCE 72
756 PAIN OF SKIN 72
757 ATRIOVENTRICULAR BLOCK FIRST DEGREE 71
758 DEVICE MALFUNCTION 71
759 EAR DISCOMFORT 71
760 FLAT AFFECT 71
761 HAEMORRHAGIC ANAEMIA 71
762 INITIAL INSOMNIA 71
763 PRODUCT USE COMPLAINT 71
764 SPINAL FRACTURE 71
765 TRICUSPID VALVE INCOMPETENCE 71
766 ACTINIC KERATOSIS 70
767 CARDIOMYOPATHY 70
768 DEPERSONALISATION/DEREALISATION DISORDER 70
769 DIABETES MELLITUS INADEQUATE CONTROL 70
770 GLOSSODYNIA 70
771 HEPATITIS 70
772 HYPOKINESIA 70
773 INTRAOCULAR PRESSURE INCREASED 70
774 ORAL DISCOMFORT 70
775 SINUS BRADYCARDIA 70
776 TRANSAMINASES INCREASED 70
777 ANAL INCONTINENCE 69
778 BONE LOSS 69
779 COORDINATION ABNORMAL 69
780 DEVICE OCCLUSION 69
781 DRUG PRESCRIBING ERROR 69
782 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 69
783 METASTASES TO BONE 69
784 SMALL INTESTINAL OBSTRUCTION 69
785 ACUTE MYELOID LEUKAEMIA 68
786 ANKLE FRACTURE 68
787 AORTIC VALVE INCOMPETENCE 68
788 BREATH SOUNDS ABNORMAL 68
789 DEVICE DISLOCATION 68
790 GALLBLADDER DISORDER 68
791 INCREASED TENDENCY TO BRUISE 68
792 OLIGURIA 68
793 REBOUND ACID HYPERSECRETION 68
794 ACTIVITIES OF DAILY LIVING IMPAIRED 67
795 BUNDLE BRANCH BLOCK RIGHT 67
796 CRYING 67
797 FLANK PAIN 67
798 INFERTILITY 67
799 ISCHAEMIC STROKE 67
800 LIVER INJURY 67
801 MYOCARDIAL ISCHAEMIA 67
802 MYOSITIS 67
803 SCAR 67
804 TARDIVE DYSKINESIA 67
805 TEMPERATURE INTOLERANCE 67
806 URINARY TRACT OBSTRUCTION 67
807 APPLICATION SITE DISCOMFORT 66
808 DIVERTICULUM INTESTINAL 66
809 HAEMORRHAGE URINARY TRACT 66
810 NERVE INJURY 66
811 POLYURIA 66
812 SEBORRHOEIC DERMATITIS 66
813 SEMEN VISCOSITY DECREASED 66
814 SQUAMOUS CELL CARCINOMA OF SKIN 66
815 TROPONIN INCREASED 66
816 ANOSMIA 65
817 DECREASED ACTIVITY 65
818 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 65
819 GENITAL DISORDER MALE 65
820 HEPATIC FAILURE 65
821 PELVIC PAIN 65
822 PNEUMOTHORAX 65
823 APPLICATION SITE INFLAMMATION 64
824 FACE OEDEMA 64
825 HYDROCELE 64
826 HYPERTENSIVE CRISIS 64
827 HYPERTONIC BLADDER 64
828 IMMUNE SYSTEM DISORDER 64
829 MYASTHENIA GRAVIS 64
830 PRODUCT PHYSICAL ISSUE 64
831 PULMONARY CONGESTION 64
832 SLUGGISHNESS 64
833 SWELLING OF EYELID 64
834 TRICHORRHEXIS 64
835 COVID-19 PNEUMONIA 63
836 EXERCISE TOLERANCE DECREASED 63
837 LISTLESS 63
838 LIVER FUNCTION TEST INCREASED 63
839 MOUTH ULCERATION 63
840 PROCEDURAL PAIN 63
841 APPLICATION SITE PARAESTHESIA 62
842 BLOOD GLUCOSE ABNORMAL 62
843 DEVICE RELATED INFECTION 62
844 DIALYSIS 62
845 EXTRA DOSE ADMINISTERED 62
846 LYMPHOCYTE COUNT DECREASED 62
847 MANIA 62
848 MUSCULOSKELETAL DISORDER 62
849 NONSPECIFIC REACTION 62
850 ABORTION SPONTANEOUS 61
851 CARDIOVASCULAR DISORDER 61
852 DUODENAL ULCER 61
853 DYSLIPIDAEMIA 61
854 FOOD INTOLERANCE 61
855 GENITAL PARAESTHESIA 61
856 HICCUPS 61
857 ON AND OFF PHENOMENON 61
858 URINARY HESITATION 61
859 DEREALISATION 60
860 GENERALISED TONIC-CLONIC SEIZURE 60
861 JOINT RANGE OF MOTION DECREASED 60
862 MULTIPLE SCLEROSIS 60
863 PRODUCT COMMUNICATION ISSUE 60
864 PRODUCT COMPLAINT 60
865 SKIN FISSURES 60
866 ULCER 60
867 WRONG PRODUCT ADMINISTERED 60
868 ABNORMAL FAECES 59
869 BLOOD LACTATE DEHYDROGENASE INCREASED 59
870 DECUBITUS ULCER 59
871 ELECTROLYTE IMBALANCE 59
872 FIBROMYALGIA 59
873 GASTROENTERITIS 59
874 GASTROINTESTINAL PAIN 59
875 LOWER LIMB FRACTURE 59
876 ORAL HERPES 59
877 PARAESTHESIA ORAL 59
878 PERIORBITAL SWELLING 59
879 PHARYNGITIS 59
880 PHYSICAL DISABILITY 59
881 PRESCRIBED OVERDOSE 59
882 SECRETION DISCHARGE 59
883 SELF ESTEEM DECREASED 59
884 WEIGHT FLUCTUATION 59
885 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 59
886 ADVERSE REACTION 58
887 COLON CANCER 58
888 CORONARY ARTERY STENOSIS 58
889 MALE GENITAL ATROPHY 58
890 MALNUTRITION 58
891 SEDATION 58
892 SHOCK 58
893 SPUTUM DISCOLOURED 58
894 STEVENS-JOHNSON SYNDROME 58
895 TACHYARRHYTHMIA 58
896 TRANSFUSION 58
897 APPLICATION SITE HAEMORRHAGE 57
898 BACTERAEMIA 57
899 BLOOD CALCIUM DECREASED 57
900 EOSINOPHILIA 57
901 INTENTIONAL DRUG MISUSE 57
902 MULTIPLE ORGAN DYSFUNCTION SYNDROME 57
903 SKIN WRINKLING 57
904 SPINAL STENOSIS 57
905 URINE ODOUR ABNORMAL 57
906 APHONIA 56
907 DRY THROAT 56
908 ECCHYMOSIS 56
909 FRACTURE 56
910 HYPOTONIA 56
911 MULTIPLE SCLEROSIS RELAPSE 56
912 MUSCLE RIGIDITY 56
913 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 56
914 SKIN INFECTION 56
915 TRANSMISSION OF DRUG VIA SEMEN 56
916 ATAXIA 55
917 BEDRIDDEN 55
918 BREAST SWELLING 55
919 CHOLESTASIS 55
920 HYPERCALCAEMIA 55
921 INCREASED APPETITE 55
922 LUNG INFILTRATION 55
923 PROSTATIC OPERATION 55
924 SKIN PAPILLOMA 55
925 SPINAL OPERATION 55
926 UPPER LIMB FRACTURE 55
927 UPPER-AIRWAY COUGH SYNDROME 55
928 VARICOSE VEIN 55
929 DRUG RESISTANCE 54
930 FOOT DEFORMITY 54
931 HEPATITIS CHOLESTATIC 54
932 LARYNGITIS 54
933 PANIC REACTION 54
934 PROCTALGIA 54
935 RESPIRATORY ARREST 54
936 SALIVARY HYPERSECRETION 54
937 BLOOD TESTOSTERONE INCREASED 53
938 CARDIOGENIC SHOCK 53
939 CHOLECYSTECTOMY 53
940 DERMATITIS ALLERGIC 53
941 DRUG DISPENSING ERROR 53
942 GENERALISED ANXIETY DISORDER 53
943 NEPHROPATHY 53
944 OSTEONECROSIS OF JAW 53
945 PLATELET COUNT INCREASED 53
946 PRODUCT ADMINISTRATION INTERRUPTED 53
947 PROSTATE CANCER METASTATIC 53
948 PULMONARY THROMBOSIS 53
949 RASH MACULO-PAPULAR 53
950 RENAL PAIN 53
951 SPERMATOZOA ABNORMAL 53
952 SUBARACHNOID HAEMORRHAGE 53
953 TOOTH FRACTURE 53
954 URINE OUTPUT DECREASED 53
955 CARDIAC FAILURE CHRONIC 52
956 CARDIAC PACEMAKER INSERTION 52
957 CARDIAC TAMPONADE 52
958 EMOTIONAL POVERTY 52
959 EYE HAEMORRHAGE 52
960 HEMIPARESIS 52
961 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 52
962 OESOPHAGITIS 52
963 RENAL CANCER 52
964 SCRATCH 52
965 TOOTH ABSCESS 52
966 TOOTH EXTRACTION 52
967 AORTIC ARTERIOSCLEROSIS 51
968 BLOOD TEST ABNORMAL 51
969 CANDIDA INFECTION 51
970 CONJUNCTIVITIS 51
971 DRUG DISPENSED TO WRONG PATIENT 51
972 GASTROENTERITIS VIRAL 51
973 HAIR TRANSPLANT 51
974 HIP ARTHROPLASTY 51
975 KIDNEY INFECTION 51
976 LYMPHOMA 51
977 NERVE COMPRESSION 51
978 PANIC DISORDER 51
979 PNEUMONIA BACTERIAL 51
980 SINUS CONGESTION 51
981 SKIN SWELLING 51
982 SKIN TIGHTNESS 51
983 SNORING 51
984 TACHYPNOEA 51
985 THERAPY CHANGE 51
986 VITAMIN D DECREASED 51
987 AUTONOMIC NERVOUS SYSTEM IMBALANCE 50
988 DARK CIRCLES UNDER EYES 50
989 DEMENTIA ALZHEIMER^S TYPE 50
990 EMPHYSEMA 50
991 FOLLICULITIS 50
992 FREEZING PHENOMENON 50
993 GASTRIC HAEMORRHAGE 50
994 IMMUNODEFICIENCY 50
995 INFUSION SITE PAIN 50
996 PELVIC FRACTURE 50
997 REPRODUCTIVE TRACT DISORDER 50
998 SUPRAVENTRICULAR TACHYCARDIA 50
999 TOOTH LOSS 50